HD-OPM Archive
Topics › Statins

Statins may help overcome cancer resistance to immunotherapy by blocking PD-L1 release

Louis Nervegna · Mar 06, 2026 · ♥ 7 reactions · 0 comments · original Facebook post
StatinsCancer
AI summary & key facts

Reports a newly described mechanism by which cancers shed immunosuppressive PD-L1 on extracellular vesicles, which statins may interfere with. Because statins are cheap and widely used, the finding could translate to the clinic quickly, though this is early mechanistic work.

Statins might help to overcome resistance that certain cancers have to immunotherapy.

Quoted:

These findings help explain why immune checkpoint inhibitors fail in many patients. By uncovering a new mechanism that controls the release of immunosuppressive PD-L1 through extracellular vesicles, the study reveals a previously hidden contributor to immune resistance.

The connection to statins is especially significant because these medications are widely prescribed, affordable, and generally safe. This raises the possibility that the discovery could be translated into clinical use relatively quickly. As the researchers noted, “In the long term, this research may lead to more effective and accessible cancer immunotherapies. It could help more patients benefit from immune checkpoint treatments, improving survival and quality of life in real-world settings.”

scitechdaily.comA Common Drug May Make Cancer Immunotherapy Work BetterA newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.scitechdaily.com

#statinsHD #statinscancerHD #immunotherapyHD

Research cited

← newer: Hypothesis: disrupted iron handling after SARS-CoV-2 infectiolder: One in three people will develop atrial fibrillation; lifest →